Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients

Transplantation. 2021 Oct 1;105(10):e146-e147. doi: 10.1097/TP.0000000000003883.

Authors

Arnaud Del Bello^{1

2}, Olivier Marion^{1

2

3}, Camille Vellas⁴, Stanislas Faguer^{1

3}, Jacques Izopet^{2

3

4}, Nassim Kamar^{1

2

3}

Affiliations

¹ Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France.
² INFINITY- Inserm U1291-CNRS U5051, Toulouse, France.
³ Paul Sabatier University, Toulouse, France.
⁴ Laboratory of Virology, Toulouse Purpan University Hospital, INSERM, Toulouse, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal / adverse effects
COVID-19*
Humans
Organ Transplantation* / adverse effects
SARS-CoV-2
Transplant Recipients

Substances

Antibodies, Monoclonal